Trial Profile
Cardiovascular Consequences of Obstructive Sleep Apnea (OSA): Role of Endothelin and Preventive Effects of Bosentan.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms BOSAS
- 08 Dec 2015 Primary endpoint has not been met. (24 hour mean diastolic blood pressure), as per an article published in the Respirology
- 08 Dec 2015 Results published in the Respirology
- 20 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.